NDC 62559-306

Lipofen

Fenofibrate

Lipofen is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Ani Pharmaceuticals, Inc.. The primary component is Fenofibrate.

Product ID62559-306_25f18a1a-2283-469b-a18f-e573fa72a1ee
NDC62559-306
Product TypeHuman Prescription Drug
Proprietary NameLipofen
Generic NameFenofibrate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2021-09-24
Marketing CategoryNDA /
Application NumberNDA021612
Labeler NameANI Pharmaceuticals, Inc.
Substance NameFENOFIBRATE
Active Ingredient Strength150 mg/1
Pharm ClassesPeroxisome Proliferator Receptor alpha Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 62559-306-90

90 CAPSULE in 1 BOTTLE (62559-306-90)
Marketing Start Date2021-09-24
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Lipofen" or generic name "Fenofibrate"

NDCBrand NameGeneric Name
66869-147LIPOFENLIPOFEN
66869-137LIPOFENLIPOFEN
0093-7755FenofibrateFenofibrate
0093-7756FenofibrateFenofibrate
0115-0511FenofibrateFENOFIBRATE
0115-0522FenofibrateFENOFIBRATE
0115-0533FenofibrateFENOFIBRATE
0115-1522FenofibrateFenofibrate
0115-1523FenofibrateFenofibrate
0115-5511FENOFIBRATEFENOFIBRATE
0115-5522FENOFIBRATEFENOFIBRATE
0074-3173TricorFenofibrate
0074-3189TricorFenofibrate

Trademark Results [Lipofen]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LIPOFEN
LIPOFEN
78688955 3403114 Live/Registered
Cipher Pharmaceuticals Inc.
2005-08-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.